查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1574260

囊腫纖維化設備市場：按產品、最終用戶、年齡層、治療方法- 全球預測 2025-2030

Cystic Fibrosis Devices Market by Product (Accessories, Devices), End User (Ambulatory Surgical Centers, Clinics, Homecare Settings), Age Group, Therapy - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

囊腫纖維化設備市場2023年估值為29.3億美元，預計到2024年將達到32億美元，複合年成長率為10.87%，到2030年將達到60.4億美元。

囊腫纖維化(CF) 設備涵蓋一系列旨在協助管理和治療囊腫纖維化是一種影響呼吸、消化器官系統和生殖系統的遺傳性疾病。這些設備包括霧化器、氣道系統、氧氣濃縮機等，對於透過緩解呼吸道症狀和增強肺功能來改善患者的生活品質至關重要。 CF 的慢性性質和終身護理的需要強調了對這些設備的需求，這需要促進藥物輸送、幫助清除粘液並確保充足的氧氣供應。應用程式涵蓋醫院、診所和居家照護，最終用戶包括患者、醫療保健提供者和看護者。市場成長受到生物技術進步、對囊腫纖維化認知的提高以及政府加強醫療基礎設施的努力的強烈影響。個人化醫療和遠端醫療服務的興起帶來了潛在的商機，因為它們為囊性纖維化患者帶來了更量身定做和易於使用的治療選擇。公司應該透過對遠端醫療設備和個人化護理服務系統的研發投資來利用這些趨勢。然而，該市場也存在局限性，包括設備成本高、低收入地區的可及性有限以及創新的監管途徑複雜。患者數量少也是一個重大挑戰，這可能會限制大規模研究和開發的獎勵。完美的創新領域包括開發攜帶式和更高效的氣道設備，整合數位健康解決方案以更好地病患監測，以及探索基因療法的進步以提供更全面的治療選擇。市場競爭激烈，對研發的大量投資以及科技公司和醫療保健提供者之間的合作夥伴關係是永續成長的關鍵。成功創新並駕馭監管環境的公司將能夠更好地佔領這個不斷成長的市場。

主要市場統計
基準年[2023] 29.3億美元
預測年份 [2024] 32億美元
預測年份 [2030] 60.4億美元
複合年成長率（%） 10.87%

市場動態：快速發展的囊腫纖維化設備市場的關鍵市場洞察

供需的動態交互作用正在改變囊腫纖維化設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 擴大囊腫纖維化早期診斷的宣傳活動和政府舉措
    • 新型囊腫纖維化治療裝置的臨床試驗擴展和核准
    • 與醫療機構和醫療設備製造商合作開發囊腫纖維化解決方案
    • 擴大採用個人化醫療方法來治療囊腫纖維化
  • 市場限制因素
    • 嚴格的監管要求和漫長的核准流程阻礙了新設備的推出。
    • 研究和開發的資金和資源有限，減緩了囊腫纖維化治療的創新。
  • 市場機會
    • 開發數位平台和行動應用程式以加強對囊腫纖維化患者的護理和支持
    • 將人工智慧整合到囊腫纖維化設備診斷和監測中
    • 採用多學科護理方法建立囊腫纖維化診所
  • 市場挑戰
    • 特定行業的挑戰：滿足有限的患者數量並確保囊腫纖維化治療設備製造商的市場盈利
    • 行業特定的挑戰：將先進技術整合到囊腫纖維化設備中，同時保持經濟性和易用性

波特的五力戰略工具駕馭囊腫纖維化設備市場

波特的五力架構是了解囊腫纖維化設備市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解囊腫纖維化設備市場的外部影響

外部宏觀環境因素在塑造囊腫纖維化設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解囊腫纖維化設備市場的競爭格局

對囊腫纖維化設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣囊腫纖維化設備市場供應商的績效評估

FPNV 定位矩陣是評估囊腫纖維化設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了囊腫纖維化設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對囊腫纖維化設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大囊腫纖維化早期診斷的宣傳活動和政府工作
      • 擴大新型囊腫纖維化治療裝置的臨床試驗與核准
      • 醫療機構與醫療設備製造商合作開發囊腫纖維化解決方案
      • 在囊腫纖維化治療中擴大採用個人化醫療方法
    • 抑制因素
      • 嚴格的監管要求和漫長的核准流程阻礙了新設備的推出
      • 用於研發的資金和資源有限，導致囊腫纖維化治療的創新緩慢
    • 機會
      • 創建數位平台和行動應用程式以加強對囊腫纖維化患者的護理和支持
      • 將人工智慧融入囊腫纖維化診斷和監測
      • 建立囊腫纖維化診所，採用多學科護理方法
    • 任務
      • 特定產業的挑戰：為有限的患者群體提供服務並確保囊腫纖維化治療設備製造商的市場盈利
      • 特定產業的挑戰：整合先進技術，同時保持囊腫纖維化設備的經濟性和易用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章囊腫纖維化設備市場：依產品

  • 配件
    • 面具
    • 感應器
    • 管子
  • 裝置
    • 氣道清理裝置
    • 高頻胸壁振動裝置
    • 吸入器
    • 噴霧器
    • 呼氣正壓 (PEP) 裝置

第7章囊腫纖維化設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 家庭護理設置
  • 醫院
    • 綜合醫院
    • 專科醫院

第8章囊腫纖維化設備市場：依年齡層

  • 成人
    • 老年人
    • 青年
  • 老年醫學
  • 小兒科
    • 孩子們
    • 嬰兒

第9章囊腫纖維化設備市場治療

  • 營養療法
  • 藥物治療
    • 抗生素
    • 黏液溶解劑
  • 物理治療

第10章美洲囊腫纖維化設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太囊性囊腫纖維化器械市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲囊腫纖維化設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C001D

The Cystic Fibrosis Devices Market was valued at USD 2.93 billion in 2023, expected to reach USD 3.20 billion in 2024, and is projected to grow at a CAGR of 10.87%, to USD 6.04 billion by 2030.

Cystic Fibrosis (CF) devices encompass a range of medical technologies designed to assist in the management and treatment of cystic fibrosis, a genetic disorder affecting the respiratory, digestive, and reproductive systems. These devices include nebulizers, airway clearance systems, and oxygen concentrators, essential for improving patients' quality of life by alleviating respiratory symptoms and enhancing pulmonary function. The necessity of these devices is underscored by the chronic nature of CF and the need for lifelong care, facilitating drug delivery, assisting in mucus clearance, and ensuring adequate oxygenation. Application scope spans hospitals, clinics, and home care settings, with end-users including patients, healthcare providers, and caregivers. Market growth is strongly influenced by advances in biotechnology, increasing awareness of cystic fibrosis, and government initiatives to enhance healthcare infrastructure. The rise in personalized medicine and telehealth services introduces potential opportunities, as they can lead to more tailored and accessible treatment options for CF patients. Companies should capitalize on these trends through research and development investments in telemedicine-enabled devices and personalized therapy delivery systems. However, the market faces limitations such as high device costs, limited accessibility in low-income regions, and the complexity of regulatory pathways for new innovations. A significant challenge is also the small patient population, which can limit incentivization for extensive research and development. The best areas for innovation include developing portable and more efficient airway clearance devices, integrating digital health solutions for better patient monitoring, and exploring gene therapy advances for more comprehensive treatment options. The nature of the market is competitive, with significant investments in R&D and collaborations between technology companies and healthcare providers being pivotal for sustained growth. Companies that successfully innovate and navigate regulatory landscapes will be better positioned to capture this growing market.

KEY MARKET STATISTICS
Base Year [2023] USD 2.93 billion
Estimated Year [2024] USD 3.20 billion
Forecast Year [2030] USD 6.04 billion
CAGR (%) 10.87%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cystic Fibrosis Devices Market

The Cystic Fibrosis Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing awareness campaigns and government initiatives for early diagnosis of cystic fibrosis
    • Expansion of clinical trials and approval of new cystic fibrosis management devices
    • Collaborations between healthcare institutions and medical device manufacturers for cystic fibrosis solutions
    • Increasing adoption of personalized medicine approaches in the treatment of cystic fibrosis
  • Market Restraints
    • Stringent regulatory requirements and lengthy approval processes hindering the introduction of new devices
    • Limited funding and resources for research and development slowing innovation in cystic fibrosis care
  • Market Opportunities
    • Creation of digital platforms and mobile apps to enhance cystic fibrosis patient care and support
    • Integration of artificial intelligence in cystic fibrosis device diagnostics and monitoring
    • Establishment of specialized cystic fibrosis clinics with a multidisciplinary care approach
  • Market Challenges
    • Industry-specific challenge: addressing the limited patient population and ensuring market profitability for cystic fibrosis device manufacturers
    • Industry-specific challenge: integrating advanced technologies while maintaining affordability and user-friendliness in cystic fibrosis devices

Porter's Five Forces: A Strategic Tool for Navigating the Cystic Fibrosis Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cystic Fibrosis Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cystic Fibrosis Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cystic Fibrosis Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cystic Fibrosis Devices Market

A detailed market share analysis in the Cystic Fibrosis Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cystic Fibrosis Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cystic Fibrosis Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cystic Fibrosis Devices Market

A strategic analysis of the Cystic Fibrosis Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cystic Fibrosis Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Allergan plc, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Chiesi Farmaceutici S.p.A., Cyclacel Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., GlaxoSmithKline plc, Mylan N.V., Novartis AG, Pfizer Inc., ProQR Therapeutics N.V., Proteostasis Therapeutics, Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Translate Bio, Inc., and Vertex Pharmaceuticals Incorporated.

Market Segmentation & Coverage

This research report categorizes the Cystic Fibrosis Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories and Devices. The Accessories is further studied across Masks, Sensors, and Tubes. The Devices is further studied across Airway Clearance Devices, High Frequency Chest Wall Oscillation Devices, Inhalers, Nebulizers, and Positive Expiratory Pressure (PEP) Devices.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, Homecare Settings, and Hospitals. The Hospitals is further studied across General Hospitals and Specialized Hospitals.
  • Based on Age Group, market is studied across Adults, Geriatrics, and Pediatrics. The Adults is further studied across Older Adults and Young Adults. The Pediatrics is further studied across Children and Infants.
  • Based on Therapy, market is studied across Nutritional Therapy, Pharmacotherapy, and Physiotherapy. The Pharmacotherapy is further studied across Antibiotics and Mucolytics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness campaigns and government initiatives for early diagnosis of cystic fibrosis
      • 5.1.1.2. Expansion of clinical trials and approval of new cystic fibrosis management devices
      • 5.1.1.3. Collaborations between healthcare institutions and medical device manufacturers for cystic fibrosis solutions
      • 5.1.1.4. Increasing adoption of personalized medicine approaches in the treatment of cystic fibrosis
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory requirements and lengthy approval processes hindering the introduction of new devices
      • 5.1.2.2. Limited funding and resources for research and development slowing innovation in cystic fibrosis care
    • 5.1.3. Opportunities
      • 5.1.3.1. Creation of digital platforms and mobile apps to enhance cystic fibrosis patient care and support
      • 5.1.3.2. Integration of artificial intelligence in cystic fibrosis device diagnostics and monitoring
      • 5.1.3.3. Establishment of specialized cystic fibrosis clinics with a multidisciplinary care approach
    • 5.1.4. Challenges
      • 5.1.4.1. Industry-specific challenge: addressing the limited patient population and ensuring market profitability for cystic fibrosis device manufacturers
      • 5.1.4.2. Industry-specific challenge: integrating advanced technologies while maintaining affordability and user-friendliness in cystic fibrosis devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cystic Fibrosis Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
    • 6.2.1. Masks
    • 6.2.2. Sensors
    • 6.2.3. Tubes
  • 6.3. Devices
    • 6.3.1. Airway Clearance Devices
    • 6.3.2. High Frequency Chest Wall Oscillation Devices
    • 6.3.3. Inhalers
    • 6.3.4. Nebulizers
    • 6.3.5. Positive Expiratory Pressure (PEP) Devices

7. Cystic Fibrosis Devices Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Clinics
  • 7.4. Homecare Settings
  • 7.5. Hospitals
    • 7.5.1. General Hospitals
    • 7.5.2. Specialized Hospitals

8. Cystic Fibrosis Devices Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adults
    • 8.2.1. Older Adults
    • 8.2.2. Young Adults
  • 8.3. Geriatrics
  • 8.4. Pediatrics
    • 8.4.1. Children
    • 8.4.2. Infants

9. Cystic Fibrosis Devices Market, by Therapy

  • 9.1. Introduction
  • 9.2. Nutritional Therapy
  • 9.3. Pharmacotherapy
    • 9.3.1. Antibiotics
    • 9.3.2. Mucolytics
  • 9.4. Physiotherapy

10. Americas Cystic Fibrosis Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cystic Fibrosis Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cystic Fibrosis Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AbbVie Inc.
  • 3. Allergan plc
  • 4. AstraZeneca plc
  • 5. Bayer AG
  • 6. Boehringer Ingelheim International GmbH
  • 7. Chiesi Farmaceutici S.p.A.
  • 8. Cyclacel Pharmaceuticals, Inc.
  • 9. F. Hoffmann-La Roche Ltd
  • 10. Gilead Sciences, Inc.
  • 11. GlaxoSmithKline plc
  • 12. Mylan N.V.
  • 13. Novartis AG
  • 14. Pfizer Inc.
  • 15. ProQR Therapeutics N.V.
  • 16. Proteostasis Therapeutics, Inc.
  • 17. Sanofi
  • 18. Teva Pharmaceutical Industries Ltd.
  • 19. Translate Bio, Inc.
  • 20. Vertex Pharmaceuticals Incorporated

LIST OF FIGURES

  • FIGURE 1. CYSTIC FIBROSIS DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CYSTIC FIBROSIS DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CYSTIC FIBROSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CYSTIC FIBROSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CYSTIC FIBROSIS DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CYSTIC FIBROSIS DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MASKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AIRWAY CLEARANCE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HIGH FREQUENCY CHEST WALL OSCILLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY POSITIVE EXPIRATORY PRESSURE (PEP) DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SPECIALIZED HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY OLDER ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NUTRITIONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MUCOLYTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHYSIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 156. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 157. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 166. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 167. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 176. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 177. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 186. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 196. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 197. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 216. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 217. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 226. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 227. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 228. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 236. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 237. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 249. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 257. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 258. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 259. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 267. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 268. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 269. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 277. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 278. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 279. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 287. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 288. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 289. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 297. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 298. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 299. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 307. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 308. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 309. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 315. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 316. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 317. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 318. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 322. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 326. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 328. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 329. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 330. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 331. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 332. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 333. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 334. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 335. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 336. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 337. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 338. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 339. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 340. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 341. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 342. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 343. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITAL